|
DIP2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.069690E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.969900E-02 |
| Normal-vs-Stage2 |
8.061000E-01 |
| Normal-vs-Stage3 |
1.401630E-03 |
| Normal-vs-Stage4 |
1.165230E-04 |
| Stage1-vs-Stage2 |
9.480000E-02 |
| Stage1-vs-Stage3 |
1.199230E-01 |
| Stage1-vs-Stage4 |
1.477660E-02 |
| Stage2-vs-Stage3 |
1.253890E-02 |
| Stage2-vs-Stage4 |
4.202900E-03 |
| Stage3-vs-Stage4 |
3.723000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.661100E-03 |
| Normal-vs-AfricanAmerican |
1.033150E-01 |
| Normal-vs-Asian |
8.998000E-04 |
| Caucasian-vs-AfricanAmerican |
7.241200E-01 |
| Caucasian-vs-Asian |
2.498400E-01 |
| AfricanAmerican-vs-Asian |
2.435000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.804000E-03 |
| Normal-vs-Female |
1.927690E-02 |
| Male-vs-Female |
4.349800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.615900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.644000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.064200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.917930E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.087200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.206000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.355000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.967400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.613400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.708000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.121630E-01 |
| Classical-VS-Follicular |
7.581900E-02 |
| Classical-VS-Other |
1.302790E-01 |
| Classical-VS-Normal |
9.103900E-03 |
| Tall-VS-Follicular |
1.418310E-02 |
| Tall-VS-Other |
5.200800E-01 |
| Tall-VS-Normal |
2.163300E-03 |
| Follicular-VS-Other |
9.863900E-02 |
| Follicular-VS-Normal |
5.628000E-01 |
| Other-VS-Normal |
9.698600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.286090E-02 |
| Normal-vs-N1 |
2.372400E-04 |
| N0-vs-N1 |
5.393900E-02 |
|
|
